alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › covid-19

covid-19

5 studies tagged covid-19, dated 2020-07-20 to 2023-08-30. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Acute cholangitis following mRNA COVID-19 vaccine booster in a patient receiving an anti-amyloid antibody for Alzheimer's disease: A case report 2023-08-30
  2. COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study 2022-07-14
  3. Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study 2022-07-08

Studies

5 studies carry this tag.

Date range

2020 to 2023

Top journals

  • Geriatrics & gerontology international 1
  • Journal of neurology 1
  • SAGE open medical case reports 1
  • The Lancet regional health. Europe 1
  • Translational psychiatry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Acute cholangitis following mRNA COVID-19 vaccine booster in a patient receiving an anti-amyloid antibody for Alzheimer's disease: A case report

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. SAGE open medical case reports 2023-08-30 Treatments

    A 77-year-old woman had 2 weeks of fever and flu-like symptoms starting several hours after receiving an mRNA booster for SARS-CoV-2 and the influenza vaccine, in separate shots.

  2. COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Translational psychiatry 2022-07-14 Genetics

    Emerging evidence has suggested a close correlation between COVID-19 and neurodegenerative disorders.

  3. Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. The Lancet regional health. Europe 2022-07-08 Cognitive tests and assessment

    Between August 5, 2021 and February 14, 2022, 25,971 UK CA aged 12-17 years received one dose of BNT162b2 vaccine.

  4. COVID-19 in older adults: Retrospective cohort study in a tertiary hospital in Japan

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Geriatrics & gerontology international 2020-09-13 Biomarkers

    In older patients, typical clinical symptoms and blood test changes were often absent; however, CT always contained typical findings of COVID-19, suggesting that CT may be a useful diagnostic tool.

  5. A systematic review of neurological symptoms and complications of COVID-19

    ✓ Peer-reviewed alzhub usefulness score 78 out of 100. Journal of neurology 2020-07-20 Tau biomarkers

    The most frequent neurological symptoms reported in association with COVID-19 are non-specific for the infection with SARS-CoV-2.

All topic tags with their study counts